
About Cronies Pharma & Bio-Sciences Private Limited
Data last updated:
Cronies Pharma & Bio-Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2016PTC109657. Its GSTIN is 36AAGCC4789F1ZD (Telangana).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹96 Lakh. It is led by directors Kirankumar Velaveni and Kalpana Ravanaboina.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Biotech Park, Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.19 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹9.6 Lakh (net margin 4.4%) and EBITDA of ₹33.72 Lakh (EBITDA margin 15.4%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 219% over five years.
As per MCA filings, the company has open charges of ₹3.18 Cr and satisfied charges of ₹1.89 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website croniespharma.com.
Company details
Contact details
Cronies Pharma & Bio-Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is croniespharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBuilding Cronies Plot No. 4C Mn Sc. Biotech Park Genomevalley Synergysquare – 1 Ph – 1 Tur, Kapally, Hyderabad, Telangana, India – 500078
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cronies Pharma & Bio-Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cronies Pharma & Bio-Sciences is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Cronies Pharma & Bio-Sciences Private Limited, buy the company report.
Financials of Cronies Pharma & Bio-Sciences Private Limited
FY 2025 filings availableCronies Pharma & Bio-Sciences Private Limited reported revenue of ₹2.19 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 219% over five years, including 7% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.4% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cronies Pharma & Bio-Sciences Private Limited, buy the company report.
Board of directors of Cronies Pharma & Bio-Sciences Private Limited
Cronies Pharma & Bio-Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kirankumar Velaveni Also directs: Synthovelzen Pharma Private Limited, Velzen Pharma Private Limited | Director | 14 May 2016 | 10 Years 5 Months | Current |
| Kalpana Ravanaboina | Director | 14 May 2016 | 10 Years 5 Months | Current |
Auditor
Cronies Pharma & Bio-Sciences Private Limited is audited by SYB & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SYB & Co | FY 2023 | 018000S |
Shareholding
The shareholding of Cronies Pharma & Bio-Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cronies Pharma & Bio-Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Feb 2023 | 100692992 | Others | ₹3.18 Cr | Open | |
| 27 Dec 2019 | 100326999 | State Bank of India | ₹1.89 Cr | Satisfied |
To see the full charge records of Cronies Pharma & Bio-Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Cronies Pharma & Bio-Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cronies Pharma & Bio-Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cronies Pharma & Bio-Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCC4789F1ZD | Telangana | Active | 19 Jun 2018 |
To see the full GST registrations and return filing status of Cronies Pharma & Bio-Sciences Private Limited, buy the company report.
Recent activity
Cronies Pharma & Bio-Sciences Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Kalpana Ravanaboina was appointed as Director on 14 May 2016.
Frequently asked questions
Cronies Pharma & Bio-Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 May 2016 (10+ years old) and is registered under CIN U74999TG2016PTC109657.
Cronies Pharma & Bio-Sciences has 2 current directors:
- Kirankumar Velaveni - Director
- Kalpana Ravanaboina - Director
The latest financial statements of Cronies Pharma & Bio-Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Cronies Pharma & Bio-Sciences is 36AAGCC4789F1ZD, registered in Telangana.
The CIN (Corporate Identification Number) of Cronies Pharma & Bio-Sciences is U74999TG2016PTC109657. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cronies Pharma & Bio-Sciences was incorporated on 14 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
Kalpana Ravanaboina was appointed as Director on 14 May 2016. Kirankumar Velaveni was appointed as Director on 14 May 2016.
Cronies Pharma & Bio-Sciences can be reached through the website croniespharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Cronies Pharma & Bio-Sciences is at Building Cronies Plot No. 4C Mn Sc. Biotech Park Genomevalley Synergysquare – 1 Ph – 1 Tur, Kapally, Hyderabad, Telangana, India – 500078.
Cronies Pharma & Bio-Sciences operates in the pharma industry, in the drug formulation and development segment.

